Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7135465 | BRISTOL MYERS SQUIBB | Sustained release beadlets containing stavudine |
Feb, 2023
(18 days from now) | |
US7135465
(Pediatric) | BRISTOL MYERS SQUIBB | Sustained release beadlets containing stavudine |
Aug, 2023
(6 months from now) |
Market Authorisation Date: 31 December, 2002
Treatment: Method for treating hiv-1 infection
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic